My research is focused on telling a causal story, specifically in the biomedical sciences. This work started in my PhD, where I worked on developing an EEG-based biomarker for the seizure onset zone in epilepsy patients. There are over 10 million epilepsy patients in the world that don’t respond to medication and continue to have seizures, thus the only available treatment is to surgically remove the brain area responsible for seizures. However, we do not yet understand the underlying causes and mechanisms that lead to seizure generation. We were inspired by how neurons behave dynamically during a seizure and modeled our approach using this intuition. I developed a quantitative EEG biomarker that highlights the most epileptic brain regions, which would enable improved diagnosis of epilepsy and help guide surgical treatment of patients leading to seizure freedom. This research was published in multiple conferences and journals including Nature Neuroscience and was also FDA approved as a software-medical device.